Skip to main content

Advertisement

SpringerLink
Log in

In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies

  • Original Research
  • Published:
In Silico Pharmacology Aims and scope Submit manuscript

Abstract

To explore the relationship between the structures of substituted pyrrolidine derivatives and their inhibition of dipeptidyl peptidase IV inhibitors. The QSAR, including CoMFA, CoMSIA and HQSAR, were applied to identify the key structures impacting their inhibitory potencies. The CoMFA, CoMSIA and HQSAR with cross-validated correlation coefficient (q2) value of 0.727, 0.870 and 0.939 and r2 value of 0.973, 0.981 and 0.949. Based on the structure–activity relationship revealed by the present study, we have designed a set of novel dipeptidyl peptidase IV inhibitors that showed excellent potencies in the developed models. Thus, our results allowed us to design new derivatives with desired activities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  • Ai Y, Wang ST, Sun PH, Song FJ (2011) Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as aurora a kinase inhibitors. Int J Mol Sci 12:1605–1624

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bush BL, Nachbar RB Jr (1993) Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J Comput Aided Mol Des 7:587–619

    Article  CAS  PubMed  Google Scholar 

  • Cramer RD, Patterson DE, Bunce JD (1988) Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 110(18):5959–5967

    Article  CAS  PubMed  Google Scholar 

  • Deacon CF, Johnsen AH, Holst JJ (1995) Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Meta 80(3):952–957

    CAS  Google Scholar 

  • Defronzo RA, Okerson T, Viswanathan P, Guan X, Holcombe JH, MacConell L (2008) Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloricin take: a randomized, cross-over study. Curr Med Res Opin 24:2943–2952

    Article  CAS  PubMed  Google Scholar 

  • Fukushima H, Hiratate A, Takahashi M, Mikami A, Saito-Hori M, Munetomo E, Kitano K, Chonan S, Saito H, Suzuki A, Takaoka Y, Yamamoto K (2008) Synthesis and structure-activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors. Bioorg Med Chem 16(7):4093–4106

    Article  CAS  PubMed  Google Scholar 

  • Gupta AK, Saxena AK (2011) 3D-QSAR CoMFA and CoMSIA studies on a set of diverse-adrenergic receptor antagonists. Med Chem Res 20:1455–1464

    Article  CAS  Google Scholar 

  • Gupta AK, Bhunia SS, Balaramnavar VM, Saxena AK (2011) Pharmacophore modelling, molecular docking and virtual screening for EGFR (HER 1) tyrosine kinase inhibitors. SAR QSAR Environ Res 22(3):239–263

    Article  CAS  PubMed  Google Scholar 

  • Hanefeld M, Herman GA, Wu M, Mickel C, Sanchez M, Stein PP (2007) Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes. Curr Med Res Opin 23:1329–1339

    Article  CAS  PubMed  Google Scholar 

  • Havale SH, Pal M (2009) Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes. Bioorg Med Chem 17:1783–1802

    Article  CAS  PubMed  Google Scholar 

  • Holst JJ (1999) Glucagon-like peptide 1 (GLP-1): an intestinal hormone, signaling nutritional abundance, with an unusual therapeutic potential. Trends Endocrinol Met 10(6):229–235

    Article  CAS  Google Scholar 

  • Holst JJ (2005) Therapy of type 2 diabetes mellitus based on the actions of glucagonlike peptide-1. Diabetes Metab Res Rev 18(6):430–441

    Article  Google Scholar 

  • Hui H, Zhao X, Perfetti R (2005) Structure and function studies of glucagon-like peptide-1 (GLP-1): the designing of a novel pharmacological agent for the treatment of diabetes. Diabetes Metab Res Rev 21(4):313–331

    Article  CAS  PubMed  Google Scholar 

  • Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130–4146

    Article  CAS  PubMed  Google Scholar 

  • Peters JU, Weber S, Kritter S, Weiss P, Wallier A, Boehringer M, Hennig M, Kuhn B, Loeffler BM (2004) Aminomethylpyrimidines as novel DPP-IV inhibitors: a 10(5)-fold activity increase by optimization of aromatic substituents. Bioorg Med Chem Lett 14(6):1491–1493

    Article  CAS  PubMed  Google Scholar 

  • Ping L, Chen WN, Chen WM (2011) Molecular modeling studies on imidazo [4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches. Eur J Med Chem 46:77–94

    Article  Google Scholar 

  • Pirhadi S, Ghasemi JB (2010) 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA. Eur J Med Chem 45:4897–4903

    Article  CAS  PubMed  Google Scholar 

  • Saqib U, Siddiqi MI (2009) 3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidylpeptidase-IV as anti-diabetic agents. SAR QSAR Environ Res 20:519–535

    Article  CAS  PubMed  Google Scholar 

  • Sridhara J, Foroozesha M, Stevens CLK (2011) A QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR. SAR QSAR Environ Res 22:681–697

    Article  Google Scholar 

  • SYBYL6.9, Tripos Inc., St. Louis, MO, USA

  • Turner R, Cull C, Holman R (1996) United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124:136–145

    Article  CAS  PubMed  Google Scholar 

  • UK Prospective Diabetes Study (UKPDS) Group (1998a) Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853

    Article  Google Scholar 

  • UK Prospective Diabetes Study (UKPDS) Group (1998b) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865

    Article  Google Scholar 

  • Viswanadhan VN, Ghose AK, Revankar RG, Robins RK (1989) Atomic physicochemical parameters for three dimensional structure directed quantitative structure activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J Chem Inf Comput Sci 29(3):163–172

    Article  CAS  Google Scholar 

  • Zeng J, Liu G, Tang Y, Jiang H (2007) 3D-QSAR studies on fluoro- pyrolidine amides as dipeptidyl peptidase IV inhibitors by CoMFA and CoMSIA. J Mol Model 13:993–1000

    Article  CAS  PubMed  Google Scholar 

  • Zhao X, Chen M, Huang B, Ji H, Yuan M (2011) Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) studies on a(1A)-adrenergic receptor antagonists based on pharmacophore molecular alignment. Int J Mol Sci 12:7022–7037

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are thankful to Head, School of Pharmacy, DAVV Indore for providing necessary facilities. Shikha Jain thanks the All India Council for Technical Education (AICTE), New Delhi, India, for the financial support for this research.

Author information

Authors and Affiliations

  1. School of Pharmacy, Devi Ahilya University, Indore, 452 001, India

    M. C. Sharma, S. Jain & R. Sharma

Authors
  1. M. C. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. C. Sharma.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, M.C., Jain, S. & Sharma, R. In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies. In Silico Pharmacol. 5, 13 (2017). https://doi.org/10.1007/s40203-017-0032-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40203-017-0032-2

Keywords

Search

Navigation